Logo image of ACU.CA

AURORA SOLAR TECHNOLOGIES IN (ACU.CA) Stock Fundamental Analysis

Canada - TSX-V:ACU - CA05207J1084 - Common Stock

0.015 CAD
0 (0%)
Last: 10/2/2025, 7:00:00 PM
Fundamental Rating

1

Overall ACU gets a fundamental rating of 1 out of 10. We evaluated ACU against 13 industry peers in the Electronic Equipment, Instruments & Components industry. ACU may be in some trouble as it scores bad on both profitability and health. ACU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ACU had negative earnings in the past year.
ACU had a negative operating cash flow in the past year.
In the past 5 years ACU always reported negative net income.
In the past 5 years ACU reported 4 times negative operating cash flow.
ACU.CA Yearly Net Income VS EBIT VS OCF VS FCFACU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1M -2M -3M -4M

1.2 Ratios

The Return On Assets of ACU (-59.26%) is worse than 69.23% of its industry peers.
ACU's Return On Equity of -158.89% is on the low side compared to the rest of the industry. ACU is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
ROA -59.26%
ROE -158.89%
ROIC N/A
ROA(3y)-31.68%
ROA(5y)-64.09%
ROE(3y)-64.27%
ROE(5y)-97.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACU.CA Yearly ROA, ROE, ROICACU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

ACU's Gross Margin of 53.49% is fine compared to the rest of the industry. ACU outperforms 76.92% of its industry peers.
In the last couple of years the Gross Margin of ACU has remained more or less at the same level.
ACU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y0.6%
ACU.CA Yearly Profit, Operating, Gross MarginsACU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

2

2. Health

2.1 Basic Checks

ACU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACU remains at a similar level compared to 1 year ago.
ACU has more shares outstanding than it did 5 years ago.
ACU has a worse debt/assets ratio than last year.
ACU.CA Yearly Shares OutstandingACU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ACU.CA Yearly Total Debt VS Total AssetsACU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

ACU has an Altman-Z score of -6.00. This is a bad value and indicates that ACU is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.00, ACU is doing worse than 84.62% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that ACU is not too dependend on debt financing.
ACU's Debt to Equity ratio of 0.01 is amongst the best of the industry. ACU outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -6
ROIC/WACCN/A
WACC7.97%
ACU.CA Yearly LT Debt VS Equity VS FCFACU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M

2.3 Liquidity

ACU has a Current Ratio of 1.45. This is a normal value and indicates that ACU is financially healthy and should not expect problems in meeting its short term obligations.
ACU's Current ratio of 1.45 is on the low side compared to the rest of the industry. ACU is outperformed by 61.54% of its industry peers.
ACU has a Quick Ratio of 1.45. This is a bad value and indicates that ACU is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.46, ACU is doing worse than 84.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.46
ACU.CA Yearly Current Assets VS Current LiabilitesACU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ACU have decreased strongly by -730.00% in the last year.
The Revenue for ACU has decreased by -54.70% in the past year. This is quite bad
The Revenue has been growing by 13.80% on average over the past years. This is quite good.
EPS 1Y (TTM)-730%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105%
Revenue 1Y (TTM)-54.7%
Revenue growth 3YN/A
Revenue growth 5Y13.8%
Sales Q2Q%-71.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACU.CA Yearly Revenue VS EstimatesACU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ACU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACU.CA Price Earnings VS Forward Price EarningsACU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACU.CA Per share dataACU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA SOLAR TECHNOLOGIES IN

TSX-V:ACU (10/2/2025, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-27 2025-08-27
Earnings (Next)11-27 2025-11-27
Inst Owners10.14%
Inst Owner ChangeN/A
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap3.33M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 1.44
P/tB 1.7
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.02
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -59.26%
ROE -158.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.49%
FCFM N/A
ROA(3y)-31.68%
ROA(5y)-64.09%
ROE(3y)-64.27%
ROE(5y)-97.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y0.6%
F-Score2
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49.19%
Cap/Sales 6.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.46
Altman-Z -6
F-Score2
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)48.43%
Cap/Depr(5y)52.71%
Cap/Sales(3y)3.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-730%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.7%
Revenue growth 3YN/A
Revenue growth 5Y13.8%
Sales Q2Q%-71.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-496.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-374.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-418.28%
OCF growth 3YN/A
OCF growth 5YN/A